MedPath

Prospective study on identification of effectiveness, safety and effect predictors of benralizumab for bronchial asthma

Not Applicable
Recruiting
Conditions
bronchial asthma
Registration Number
JPRN-UMIN000031951
Lead Sponsor
Japanese Red Cross Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
25
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who have previously received benralizumab 2) Patients with severe complications such as heart disease, liver disease or kidney failure 3) Patients judged unsuitable as subjects by doctor's judgment

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath